IBEX Technologies
CVE:IBTIBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.
Western Asset Municipal Partners Fund
NYSE:MNPWestern Asset Municipal Partners Fund Inc. is a closed ended fixed income mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. The fund is co-managed by Western Asset Management Company. It invests in fixed income markets of the United States. The fund primarily invests in investment grade tax exempt securities issued by municipalities. It benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The fund was formerly known as the Salomon Brothers Municipal Partners Fund. Western Asset Municipal Partners Fund Inc. was formed on January 29, 1993 and is domiciled in the United States.